Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Curr Opin Rheumatol. 2017 Sep;29(5):458–466. doi: 10.1097/BOR.0000000000000410

Table 1.

Classification Criteria for Antiphospholipid Syndrome [1]

APS is present if 1 of the clinical criteria and 1 of the laboratory criteria are met

Clinical criteria 1. Vascular thrombosis ≥1 clinical episode of arterial, venous, or small-vessel thrombosis.
2. Pregnancy morbidity
  1. ≥1 unexplained death of a morphologically normal fetus at ≥10 weeks of gestation

  2. ≥1 premature delivery of a morphologically normal fetus at <34 weeks gestation because of:

    1. Severe pre-eclampsia or eclampsia defined according to standard definition

    2. Recognized features of placental insufficiency

  3. ≥3 unexplained consecutive miscarriages at <10 weeks gestation, with maternal and paternal factors (anatomic, hormonal or chromosomal abnormalities) excluded

Laboratory criteria The presence of antiphospholipid antibodies on ≥2 occasions ≥12 weeks apart:
  1. Presence of lupus anticoagulant in plasma

  2. Medium- to high-titer anticardiolipin antibodies of IgG or IgM isoforms

  3. Medium- to high-titer anti-beta-2 glycoprotein-I (anti-β2GPI) antibodies of IgG or IgM isoforms